{"count": 3, "results": [{"_id": "27071733", "pmid": 27071733, "title": "Keratoconjunctivitis sicca exacerbation in a dog treated with systemic atenolol.", "journal": "J Small Anim Pract", "authors": ["Barsotti G", "Vezzosi T"], "date": "2016-07-01T00:00:00Z", "doi": "10.1111/jsap.12477", "meta_date_publication": "2016 Jul", "meta_volume": "57", "meta_issue": "7", "meta_pages": "379-81", "score": 50060.15, "text_hl": "After 2 months, @DISEASE_Pulmonary_Valve_Stenosis @DISEASE_MESH:D011666 @@@pulmonic stenosis@@@ was diagnosed, and the @SPECIES_9615 @@@dog@@@ commenced treatment with oral @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@; the @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@ophthalmological disease@@@ worsened dramatically within a few days. ", "citations": {"NLM": "Barsotti G, Vezzosi T. Keratoconjunctivitis sicca exacerbation in a dog treated with systemic atenolol. J Small Anim Pract. 2016 Jul;57(7):379-81. PMID: 27071733", "BibTeX": "@article{27071733, title={Keratoconjunctivitis sicca exacerbation in a dog treated with systemic atenolol.}, author={Barsotti G and Vezzosi T}, journal={J Small Anim Pract}, volume={57}, number={7}, pages={379-81}}"}}, {"_id": "21454164", "pmid": 21454164, "title": "Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach.", "journal": "Pak J Pharm Sci", "authors": ["Anitha P", "Ramkanth S", "Saleem MT", "Umasankari K", "Reddy BP", "Chetty M"], "date": "2011-04-01T00:00:00Z", "meta_date_publication": "2011 Apr", "meta_volume": "24", "meta_issue": "2", "meta_pages": "155-63", "score": 50058.22, "text_hl": "A novel aspiration in treatment of chronic @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@disease@@@ like @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ associated with other non communicable @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@disease@@@ risk factors, such as @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ is to provide greater therapeutic effect, overcome the side effects by complex therapeutic regimen and to improve @SPECIES_9606 @@@patient@@@ compliance upon administering combinational transdermal delivery of @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@Glibenclamide@@@ (G) and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ (A) which have not been tested literally. ", "citations": {"NLM": "Anitha P, Ramkanth S, Saleem MT, Umasankari K, Reddy BP, Chetty M. Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach. Pak J Pharm Sci. 2011 Apr;24(2):155-63. PMID: 21454164", "BibTeX": "@article{21454164, title={Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach.}, author={Anitha P and Ramkanth S and Saleem MT and Umasankari K and Reddy BP and Chetty M}, journal={Pak J Pharm Sci}, volume={24}, number={2}, pages={155-63}}"}}, {"_id": "10453968", "pmid": 10453968, "title": "Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma.", "journal": "Pharmacotherapy", "authors": ["Tafreshi MJ", "Weinacker AB"], "date": "1999-08-01T00:00:00Z", "doi": "10.1592/phco.19.11.974.31575", "meta_date_publication": "1999 Aug", "meta_volume": "19", "meta_issue": "8", "meta_pages": "974-8", "score": 50057.17, "text_hl": "Beta-adrenergic-blocking agents in @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@bronchospastic diseases@@@: a therapeutic dilemma.", "citations": {"NLM": "Tafreshi MJ, Weinacker AB. Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma. Pharmacotherapy. 1999 Aug;19(8):974-8. PMID: 10453968", "BibTeX": "@article{10453968, title={Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma.}, author={Tafreshi MJ and Weinacker AB}, journal={Pharmacotherapy}, volume={19}, number={8}, pages={974-8}}"}}]}